Colombo Stock Exchange turnover jumped past Rs. 10.47bn on Nov 16, led by large trades in Cargills (≈Rs.4.45bn) and Convenience Foods (≈Rs.3.98bn), while the ASPI fell 291.81 pts to 21,732.37. Off-market crossings in Dialog, Hemas and Aitken Spence added to volume; foreigners were net sellers (net outflow Rs.13.18m).
Diversified Holdings · Industrial Conglomerates · S&P SL20
Hemas Holdings PLC is a diversified Sri Lankan conglomerate with principal activities across consumer goods, healthcare, mobility, leisure, travel and aviation, and logistics and maritime services.
HHL shares are down 7.9% over the past year and last closed at Rs 32.80 on Nov 17, 2026.
Fundamentals
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | Rs 127.4B +8.0% | Rs 118.0B -3.0% | Rs 121.6B +6.7% | Rs 113.9B +44.5% | Rs 78.8B +22.2% | Rs 64.5B +4.7% | Rs 61.6B -3.8% | Rs 64.1B +26.0% |
| Operating profit | Rs 14.1B +3.2% | Rs 13.7B +15.0% | Rs 11.9B +8.7% | Rs 11.0B +61.6% | Rs 6.8B +11.9% | Rs 6.1B +70.2% | Rs 3.6B -37.1% | Rs 5.7B +33.4% |
| Net profit | Rs 9.3B +11.4% | Rs 8.3B +31.2% | Rs 6.4B +25.4% | Rs 5.1B +4.8% | Rs 4.8B +44.7% | Rs 3.3B +145.3% | Rs 1.4B -63.0% | Rs 3.7B +24.7% |
| EPS | 2.98 +10.4% | 2.70 -73.6% | 10.24 +43.0% | 7.16 +0.6% | 7.12 +30.4% | 5.46 +163.8% | 2.07 -63.4% | 5.65 +20.7% |
Compared with the same period a year earlier.
Per-share figures are as reported, not adjusted for splits.
Dividend history
All 30 dividends and ex-dates →Coming up
- Dec 4, 2026Dividend paidFirst interim dividend, Rs 0.25 a shareAnnouncement
| Ex-date | Dividend | Per share | Payment date |
|---|---|---|---|
| Nov 16, 2026 | FY2027 · first interim | Rs 0.25 | Dec 4, 2026 |
| Jun 30, 2026 | FY2026 · final | Rs 0.75 | Jul 17, 2026 |
| Nov 18, 2025 | FY2026 · first interim | Rs 0.25 | Dec 5, 2025 |
| Jun 26, 2025 | FY2025 · final | Rs 0.70 | Jul 16, 2025 |
| Nov 18, 2024 | FY2025 · first interim | Rs 1.00 | Dec 5, 2024 |
| Jun 28, 2024 | FY2024 · final | Rs 3.00 | Jul 17, 2024 |
| Nov 20, 2023 | FY2024 · first interim | Rs 0.40 | Dec 8, 2023 |
| Jul 4, 2023 | FY2023 · final | Rs 1.95 | Jul 24, 2023 |
Upcoming dividends, rights issues and splits across the CSE: dividend calendar →
| # | Company | Mkt cap | P/E | P/B | EPS | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| 1 | JKH.N0000 | Rs 337.1B | 18.6 | 0.81 | 1.02 | 4.31% | 1.58% |
| 2 | MELS.N0000 | Rs 224.9B | 11.7 | 1.39 | 16.51 | 11.91% | 4.22% |
| 3 | HAYL.N0000 | Rs 186.4B | 12.5 | 1.53 | 18.71 | 14.53% | 2.56% |
| 4 | CARS.N0000 | Rs 137.1B | 15.1 | 1.20 | 46.35 | 8.68% | 1.82% |
| 5 | CTHR.N0000 | Rs 114.0B | 14.2 | 2.90 | 39.81 | 20.36% | 2.91% |
| 6 | VONE.N0000 | Rs 106.8B | 7.5 | 0.85 | 12.45 | 11.29% | 1.60% |
| 7 | HHL.N0000 · this company | Rs 98.3B | 11.4 | 1.71 | 2.87 | 14.95% | 3.05% |
| 8 | BUKI.N0000 | Rs 87.7B | 19.8 | 1.06 | 43.50 | 6.34% | 2.35% |
| Peer median · 7 companies | - | 14.2 | 1.20 | - | - | 2.35% |
About Hemas Holdings Ltd.
Hemas Holdings PLC is a diversified Sri Lankan conglomerate with principal activities across consumer goods, healthcare, mobility, leisure, travel and aviation, and logistics and maritime services. The Group markets home and personal care and other consumer products domestically and in regional markets, and has a portfolio of businesses across pharmaceuticals, hospitals, hospitality and travel. The Healthcare vertical comprises pharmaceutical distribution and manufacturing (Morison), and a hospitals group operating facilities such as Wattala and Thalawathugoda; the Consumer vertical includes home and personal care categories and brands such as Atlas (including a 'Back to School' range). The Group also operates hotels and inbound travel businesses including Serendib Hotels (SHOT) and Anantara Peace Haven Tangalle, and maintains operations in Sri Lanka with regional presence in Bangladesh, West Bengal and Myanmar. Hemas positions itself as a national leader in consumer and healthcare solutions, seeking to develop brands, commercial partnerships and manufacturing capacity while engaging in route-to-market and regulatory initiatives relevant to its sectors.
AI analysis
bullishEvidence points bullish: annual profit growth and a net-cash balance sheet support a moderately undervalued price. The latest quarter's profit slipped despite higher sales.
Read the full report (Nov 18, 2026) →News sentiment
Describes news flow, not a forecastHigher than 58% of its last 19 months · 7 of 11 in its sector
10 articles in 30 days: 6 positive, 1 negative, 3 neutral.
Hemas Holdings' Hemas Hospital Wattala performed Sri Lanka's first private-sector pediatric liver transplant, creating local capacity for complex pediatric liver care and expanding treatment options for children who previously faced seeking care overseas.
Sri Lanka's CSE closed down 0.41% as the ASPI fell 90.46 points to 22,032.93, with market turnover of LKR 4.82 billion and the banking group leading turnover at LKR 1.18 billion. Notable movers included gains for Dialog, Distilleries, Ceylon Cold Stores, Aitken Spence and DFCC, while HNB, Overseas Realty, Commercial Bank, Hayleys and Carson Cumberbatch were laggards.
Colombo Stock Exchange trended lower ahead of the National Budget: ASPI down 0.27% (60.10 pts) at 22,063.29, S&P SL20 down 0.28%, market turnover Rs 1.42bn with Materials leading turnover at Rs 354.73m. Top gainers included Dialog, Distilleries and Ceylon Cold Stores, while Singer, Carson Cumberbatch and Janashakthi were top decliners; dividends were announced by Dialog, Ceylon Grain Elevators and Three Acre Farms.
Colombo Stock Exchange's ASPI rose 2.75% to 22,123.39 on Tuesday, lifted by lower oil prices and hopes of US tariff adjustments. Top gainers included Vallibel One, Dialog Axiata, Commercial Bank, Hayleys and HNB; market turnover was 7.96 billion rupees, led by the banking sector.
Hemas Holdings reported a September-quarter net profit of Rs.2.00bn, down 3.0% y/y. Revenue rose 17.0% to Rs.37.79bn but gross margin contracted to 29.7% and finance costs surged 149.4% to Rs.464.3m; board declared an interim dividend of Rs.0.25.
Hemas Holdings (HHL.N0000) reported H1 FY27 revenue of Rs.66.6bn, up 9.5% YoY, driven by a strong Q2 (Rs.37.8bn, +17.0%) and EBITDA rebounding 10.5% YoY to Rs.4.5bn; group earnings fell 3.0% YoY due to higher finance costs from working-capital borrowings and the Twiga acquisition.
Hemas Holdings reported 1H FY27 revenue of Rs. 67.0 billion, up 9.5% YoY, after a strong 2Q when revenue rose 17% YoY to Rs. 37.8 billion and EBITDA rebounded to Rs. 4.5 billion. All four segments grew and the group completed a 75% acquisition of East Africa's Twiga.
Dividend · Rs 0.25 · XD Nov 16, 2026
First Interim dividend of LKR 0.25/share; XD 2026-11-16; record 2026-11-17; payable 2026-12-04; FY 31.03.2027
Colombo stocks rebounded for a second session as the ASPI rose 1.41% (277.55 pts) to 19,970.22 and the S&P SL20 gained 1.43%. Turnover was nearly Rs.2.2bn with foreign investors net sellers of Rs.894.3m; top contributors were COMB, DIAL, HNB, HHL and CIC, and telecoms led turnover with a 39% share.